
A recent study compared the performance of Avastin, a cancer treatment drug and Ludentis, a drug used to treat a degenerative eye disease, which showed that both drugs performed with the same level of efficiency in treating age-related macular degeneration.
Patients who received monthly doses of Avastin were benefitted by a 8.0 letters of visual acuity as compared to an 8.5 letter improvement produced by the drug Ludentis.
Advertisement
Both drugs are manufactured by the same company, Genentech, but are differently priced.
While a single dose of Avastin costs about $50, patients will have to cough up so much more for a single dose of Ludentis, priced at about $2,000.
Source: Medindia
Source: Medindia
Advertisement
Advertisement